1. Home
  2. GPMT vs VXRT Comparison

GPMT vs VXRT Comparison

Compare GPMT & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPMT
  • VXRT
  • Stock Information
  • Founded
  • GPMT 2015
  • VXRT N/A
  • Country
  • GPMT United States
  • VXRT United States
  • Employees
  • GPMT N/A
  • VXRT N/A
  • Industry
  • GPMT Real Estate Investment Trusts
  • VXRT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GPMT Real Estate
  • VXRT Health Care
  • Exchange
  • GPMT Nasdaq
  • VXRT Nasdaq
  • Market Cap
  • GPMT 122.5M
  • VXRT 119.0M
  • IPO Year
  • GPMT 2017
  • VXRT N/A
  • Fundamental
  • Price
  • GPMT $2.39
  • VXRT $0.58
  • Analyst Decision
  • GPMT Buy
  • VXRT Strong Buy
  • Analyst Count
  • GPMT 3
  • VXRT 2
  • Target Price
  • GPMT $2.75
  • VXRT $3.00
  • AVG Volume (30 Days)
  • GPMT 542.7K
  • VXRT 9.1M
  • Earning Date
  • GPMT 08-04-2025
  • VXRT 08-07-2025
  • Dividend Yield
  • GPMT 8.77%
  • VXRT N/A
  • EPS Growth
  • GPMT N/A
  • VXRT N/A
  • EPS
  • GPMT N/A
  • VXRT N/A
  • Revenue
  • GPMT N/A
  • VXRT $47,395,000.00
  • Revenue This Year
  • GPMT N/A
  • VXRT N/A
  • Revenue Next Year
  • GPMT $31.11
  • VXRT N/A
  • P/E Ratio
  • GPMT N/A
  • VXRT N/A
  • Revenue Growth
  • GPMT N/A
  • VXRT 433.43
  • 52 Week Low
  • GPMT $1.61
  • VXRT $0.29
  • 52 Week High
  • GPMT $3.66
  • VXRT $1.07
  • Technical
  • Relative Strength Index (RSI)
  • GPMT 48.51
  • VXRT 59.05
  • Support Level
  • GPMT $2.26
  • VXRT $0.48
  • Resistance Level
  • GPMT $2.62
  • VXRT $0.78
  • Average True Range (ATR)
  • GPMT 0.13
  • VXRT 0.08
  • MACD
  • GPMT -0.04
  • VXRT 0.02
  • Stochastic Oscillator
  • GPMT 31.82
  • VXRT 50.00

About GPMT Granite Point Mortgage Trust Inc.

Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the property.

About VXRT Vaxart Inc

Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.

Share on Social Networks: